| ID | Name | CAS | Properties |
MW (g/mol) |
| 121-893-6 |
Benzeneacetic acid, 3-methoxy-«alpha»,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
|
2 | 414.72 |
| 121-980-9 |
5-Pregnan-11-one, 3«alpha»,20«alpha»,21-trihydroxy, EO-TMS
|
|
2 | 610.10 |
| 121-991-7 |
L-Tyrosine, N,O-bis(trimethylsilyl)-3-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55638-45-4 |
2 | 485.91 |
| 122-004-1 |
13,14-Dihydro-15-keto-PGF1A, EO-TMS, isomer # 2
|
|
2 | 616.12 |
| 122-050-0 |
3«alpha»,7«alpha»,12«alpha»,25-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 769.40 |
| 122-063-6 |
4-(2-Hydroxyethyl)-2,2-dimethyl-1,3-dioxolane, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 271.43 |
| 122-147-3 |
4,7,13,16-Tetraoxa-1,10-dithiacyclooctadecane-1,10-bis-p-tolyl-sulfonylimido- (alpha-form)
|
119698-57-6 |
2 | 634.85 |
| 122-177-0 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, 19-hydroxy, EO-TMS # 2
|
|
2 | 714.28 |
| 122-220-1 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(2-chloroethyl)
|
|
2 | 328.21 |
| 122-247-2 |
13,14-Dihydro-15-keto-PGF2A, EO-TMS, isomer # 2
|
|
2 | 614.11 |
| 122-275-1 |
Methyl 5-.beta.-cholan-7-.alpha.-ol-3-one-24-oate, oxime, TMS # 1
|
|
2 | 563.97 |
| 122-280-5 |
9-Oxo-11-octadecenoic acid, 13-hydroxy, PFBO, TMS, methyl ester, # 1
|
|
2 | 593.74 |
| 122-330-9 |
Phosphoric acid, 2-(trimethylsiloxy)-1-[(trimethylsiloxy)methyl]ethyl bis(trimethylsilyl) ester
|
|
2 | 460.80 |
| 122-337-2 |
N-(2-Hydroxy-1-phenyl-ethyl)-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
2 | 421.71 |
| 122-388-6 |
2-Pyridinecarbamic acid, 4-(allylamino)-6-amino-5-nitro-, ethyl ester
|
|
2 | 281.27 |
| 122-427-2 |
1,3(5«beta»)-androsten-3,17«beta»-diol di-TMS
|
|
2 | 432.79 |
| 122-472-2 |
Disiloxane, 1,1,3,3-tetramethyl-1,3-bis(pentafluorophenyl)-
|
19091-32-8 |
2 | 466.42 |
| 122-595-6 |
1-Chloro-3-methoxy-propan-2-ol, tert-butyldimethylsilyl ether
|
|
2 | 238.83 |
| 122-663-0 |
2-[(3-Hydroxy-2,2,4,4-tetramethyl)cyclobutoxy]-3-methylpyrazine
|
|
2 | 236.32 |
| 122-731-4 |
13,14-Dihydro-15-keto-PGF2A, MO-TMS, isomer # 2
|
|
2 | 600.08 |
| 122-761-1 |
2,3-Dihydroxypropyl-(2-hydroxy-1-hydroxymethyl)ethylamine, tetrakis-TMS
|
|
2 | 453.91 |
| 122-820-5 |
Glycine, N-(2-methyl-1-oxo-2-butenyl)-N-(trimethylsilyl)-, trimethylsilyl ester, (E)-
|
55517-45-8 |
2 | 301.53 |
| 123-068-0 |
3H-naphth[1,2-d]imidazole, 3-(p-anisidino)-2-(p-methoxyphenyl)-
|
13847-93-3 |
2 | 395.45 |
| 123-128-3 |
Methyl 5-«beta»-cholan-3,7-dione-24-oate, oxime, TMS # 2
|
|
2 | 576.96 |
| 123-147-2 |
Silane, diphenylisohexyloxy(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
2 | 514.52 |
| 123-195-9 |
Prosta-8(12),13-dien-1-oic acid, 9-oxo-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (13E,15S)-
|
56009-41-7 |
2 | 480.83 |
| 123-212-9 |
trans-3-Hydroxycinnamic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 392.68 |
| 123-363-2 |
tert-Butyl(dimethyl)silyl-2-{[tert-butyl(dimethyl)silyl]oxy}-3-(4-{[tert-butyl(dimethyl)silyl]oxy}phenyl)acrylate
|
|
2 | 522.94 |
| 123-605-3 |
Glycine, N-(trimethylsilyl)-N-[4-[(trimethylsilyl)oxy]benzoyl]-, trimethylsilyl ester
|
55517-55-0 |
2 | 411.72 |
| 123-845-7 |
1-«beta»,3-«alpha»,7-«alpha»,12-«alpha»-Tetrahydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 727.32 |
| 123-904-1 |
4-Aminobenzoic acid, N,N-bis(acetyl)-, tert.-butyldimethylsilyl ester
|
|
2 | 335.48 |
| 123-926-7 |
2,4-dimethyl-2,4,6,6,8,8-hexaphenyl-[1,3,5,7,2,4,6,8]cyclotetrasiloxane
|
|
2 | 669.03 |
| 123-940-1 |
9,10-epoxy-18-hydroxyoctadec-12-enoic acid, TMSi ester TMSi ether
|
|
2 | 456.81 |
| 124-001-2 |
Pregnane-3,20-dione, 17-[(trimethylsilyl)oxy]-, bis(O-methyloxime), (5«beta»)-
|
57305-29-0 |
2 | 462.74 |
| 124-004-9 |
Urea,[4-(2-furylmethyl(methyl)amino)-2,2-diphenyl-n-butyl]-
|
|
2 | 377.49 |
| 124-083-2 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 3
|
|
2 | 811.58 |
| 124-125-5 |
3,4-Dihydroxy-dl-phenylalanine, N,O,O'-tris(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 654.23 |
| 124-129-1 |
2-Aminobenzoic acid, N- trifluoroacetyl -, N,O-bis(tert.-butyldimethylsilyl)-
|
|
2 | 461.67 |
| 124-243-4 |
Androstan-16-one, 3-[(trimethylsilyl)oxy]-, O-methyloxime, (3«beta»,5«alpha»)-
|
57305-08-5 |
2 | 391.66 |
| 124-341-5 |
Trimethylsilyl 2-amino-4-oxo-4-pyrrol2-[(trimethylsilyl)amino]phenylmorphobutanoate
|
|
2 | 352.58 |
| 124-387-5 |
Cholan-24-oic acid, 3,7,12-tri(trimethylsilyloxy)-, trimethylsilyl ester, (3«alpha», 5«beta», 7«alpha», 12«alpha»)-
|
|
2 | 697.31 |
| 124-493-7 |
Adenosine, 5'-S-methyl-5'-thio-N-(trimethylsilyl)-2',3'-bis-O-(trimethylsilyl)-
|
54623-28-8 |
2 | 513.88 |
| 124-510-7 |
5-Cholesten-3-«beta»,7-«alpha»,12-«alpha»,24,25-pentol, TMS, # 1
|
|
2 | 811.58 |
| 124-535-0 |
Pyrimidine, 6-oxo-5-acetyl-4-hydroxy-1,6-dihydro-
|
98792-81-5 |
2 | 154.12 |
| 124-546-8 |
Fluoxymesterone M (Androst-4-en-9A-fluoro-17A-methyl-3A,6B,11B,17B-tetrol), TMS
|
|
2 | 643.18 |
| 124-548-6 |
Gentisic acid, O,O'-bis(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 496.90 |
| 124-592-7 |
Glycine, N-(2-methyl-1-oxopropyl)-N-(trimethylsilyl)-, trimethylsilyl ester
|
55530-55-7 |
2 | 289.52 |
| 124-632-2 |
1-(4-Trimethylsilyloxycarbonylphenyl)-2-(pyrrolidin-1-yl)-butan-1-one
|
|
2 | 333.50 |
| 124-633-1 |
Benzoic acid, 4-(1-trimethylsilyloxy)-2-(pyrrolidin-1-yl)butyl-, trimethylsilyl ester
|
|
2 | 407.69 |
| 124-635-9 |
Pyrrolidin-2-one, 1-[1-(4-trimethylsilyloxycarbonylphenyl)butan-1-ol-2-yl]-, trimethylsilyl ether
|
|
2 | 421.69 |
| 124-636-8 |
Pyrrolidin-2-one, 1-[1-(4-trimethylsilyloxycarbonylphenyl)butan-1-one-2-yl]-
|
|
2 | 347.48 |
| 124-693-5 |
5-(Dichloromethyl)dimethylsilyloxy-2,6-dimethylnon-1-en-3-yne
|
|
2 | 307.34 |
| 124-721-3 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 3,7-dimethyl-1-phenyl-
|
2097-20-3 |
2 | 279.41 |
| 124-724-0 |
3-Ethoxy-3-hydroxyacrylic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 360.64 |
| 124-726-8 |
Prosta-8(12),13-dien-1-oic acid, 9-(ethoxyimino)-15-[(trimethylsilyl)oxy]-, trimethylsilyl ester, (13E,15S)-
|
56009-45-1 |
2 | 523.90 |
| 124-792-5 |
3«alpha»,6«alpha»,7«alpha»,12«alpha»-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
|
2 | 769.40 |
| 124-794-3 |
3-oxy-7«alpha»,12«alpha»-dihydroxy-5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 679.21 |
| 125-059-8 |
Butanoic acid, 2-[(tert-butyldimethylsilyl)oxy]-3-methyl-, tert-butyldimethylsilyl ester
|
|
2 | 346.66 |
| 125-141-6 |
Nigerotriose: aD-Glcp(1->3)-aDGlcp(1->3)-DGlc, oxime-TMS, isomer # 2
|
|
2 | 1385.63 |
| 125-252-3 |
Pregn-4-en-17-ol, 3,20-bis[(trimethylsilyl)oxy]-, (3.beta.,20S)-
|
|
2 | 478.87 |
| 10-569-9 |
6-Azido-5-tert-butyldiphenylsilyloxy-2,3,6-trideoxy-D-threo-hexofuranose
|
|
1 | 0.00 |
| 10-808-3 |
(1R,9S)-1-Acetoxy-N-acetyl-1,9-dihydro-anhydronornarceine
|
|
1 | 0.00 |
| 12-183-5 |
Acenaphthene-cis-1,2-diol, 2-(N,N-dimethylaminomethyl)-ferroceneboronate
|
|
1 | 437.12 |
| 12-480-5 |
Cobalt,(«eta»5-2,4-cyclopentadien-1-yl)[(1,2,3,4,5,6-«eta»)-1-phenylboratabenzene]-
|
36682-12-9 |
1 | 277.03 |
| 14-687-4 |
1,6-Dioxaspiro[4,4]nona-2,8-diene, 7-(2,4)-hexadiynylidene
|
|
1 | 0.00 |
| 15-432-5 |
Copper,[[2,2'-thiobis(3,1-propanediylnitrilomethylidyne)]bis[phenolato]](2-)-N,N',O,O']-,(SP-4-2)-
|
52358-04-0 |
1 | 418.01 |
| 16-509-9 |
Cobalt, [(1,2,5,6-«eta»)-1,5-cyclooctadiene](«eta»5-2,4-cyclopentadien-1-yl)-
|
12184-35-9 |
1 | 232.21 |
| 16-698-0 |
Palladium,[2,3,7,8,12,13,17,18-octaethyl-21H,23H-porphinato(2-)-N21,N22,N23,N24]-(SP-4-1)-
|
24804-00-0 |
1 | 639.18 |
| 17-019-2 |
(2S,3S)-Butane-2,3-diol, 2-(N,N-dimethylaminomethyl)-ferroceneboronate
|
|
1 | 341.03 |
| 17-037-2 |
2,4,6,8,10-Pentaethyl-2,4,6,8,10-pentamethylcyclopentasiloxane
|
|
1 | 440.91 |
| 18-908-4 |
2,3,7,8,12,13,17,18-Octaethyl-21H,23H-porphine magnesium(II)
|
20910-35-4 |
1 | 557.07 |
| 19-118-0 |
Nickel,[[2,2'-[1,7-heptanediylbis(nitrilomethylidyne)]bis[phenolato]](2-)-N,N',O,O']-
|
52358-03-9 |
1 | 395.12 |
| 21-166-4 |
Laminaritriose: bD-Glcp(1->3)-bDGlcp(1->3)-DGlc, oxime-TMS, isomer # 2
|
|
1 | 1385.65 |
| 21-814-4 |
3,18,20-Trioxo-11«beta»,17«alpha»,21-trihydroxy-4-pregnene, MO-TMS, anti
|
|
1 | 680.12 |
| 23-639-7 |
[14C] GA25 16.alpha., 17-H2, 17-OH , methyl ester
|
|
1 | 0.00 |
| 23-852-0 |
Androst-1,4-dien-17.alpha.-methyl-6.beta.,17.beta.-diol-3-one, TMS
|
|
1 | 0.00 |
| 26-388-3 |
L-Leucine, N-(tert-butyldimethylsilyl)-N-methyl-, tert-butyldimethylsilyl ester
|
|
1 | 373.72 |
| 26-669-1 |
Iron,dicarbonyl-2,4-cyclopentadiene-1-yl(«eta»5-2,4-cyclopentadien-1-yl)-
|
12247-96-0 |
1 | 242.05 |
| 29-869-6 |
Cobalt, [(1,2,3,4-«eta»)-1,3-cyclohexadiene](«eta»5-2,4-cyclopentadien-1-yl)-
|
38959-22-7 |
1 | 204.15 |
| 30-173-6 |
Ascorbic acid, 2,3,5,6-tetrakis-O-(tert-butyldimethylsilyl)-
|
|
1 | 633.18 |
| 32-076-2 |
Tungsten, dicarbonyl(«eta»5-2,4-cyclopentadien-1-yl)(«eta»3-2-propenyl)-
|
31811-41-3 |
1 | 346.03 |
| 32-973-6 |
3H-2-Benzopyran-7-carboxylic acid, 4,6-dihydro-8-hydroxy-3,4,5-trimethyl-6-oxo-, (3S-trans)-
|
112245-94-0 |
1 | 250.25 |
| 33-431-6 |
Indol-2(3h)-one, 3-(2-benzylamino)ethyl-3-phenyl-, hydrochloride
|
|
1 | 378.90 |
| 34-242-5 |
Rhodium-1,3,5,7-tetramethyl-2,4,6,8-tetraethylporphyrine complex, methyl
|
|
1 | 596.61 |
| 34-499-1 |
Rhodium, [(1,2,5,6-«eta»)-1,5-cyclooctadiene](«eta»5-2,4-cyclopentadien-1-yl)-
|
32610-45-0 |
1 | 276.18 |
| 34-627-8 |
Zirconium,bis(«eta»5-2,4-cyclopentadien-1-yl)diiodo-
|
1298-41-5 |
1 | 475.22 |
| 34-727-7 |
Indane-cis-1,2-diol, 2-(N,N-dimethylaminomethyl)-ferroceneboronate
|
|
1 | 401.09 |
| 34-876-2 |
Hexacarbonylbis(«eta»5-cyclopenta-2,4-dien-1-yl)dimolybdenum
|
12091-64-4 |
1 | 490.13 |
| 35-212-7 |
Cyclobutanone, 3,3'-(dimethylsilyldioxy) bis-2,2,4,4-tetramethyl
|
|
1 | 340.54 |
| 35-990-4 |
Chromium,(«eta»6-benzene)(«eta»5-2,4-cyclopentadien-1-yl)-
|
12093-16-2 |
1 | 195.20 |
| 40-096-1 |
Rhodium, bis(«eta»2-ethene)(1,1,1-trifluoro-2,4-pentanedionato-O,O')-
|
69372-77-6 |
1 | 312.09 |
| 41-440-7 |
Vanadium, («eta»7-cycloheptatrienylium)(«eta»5-2,4-cyclopentadien-1-yl)-
|
12636-68-9 |
1 | 207.17 |
| 42-425-3 |
6-Azido-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-D-erythro-hexofuranose
|
|
1 | 0.00 |
| 44-703-2 |
1,2,3,4-Tetrahydroanthracene-cis-1,2-diol, ferrocenylboronate
|
|
1 | 408.08 |
| 46-866-0 |
Inulotriose: bD-Fruf(2->1)-bDFruf(2->1)-DFru, oxime-TMS, isomer # 1
|
|
1 | 0.00 |
| 48-142-1 |
Titanium, («eta»8-1,3,5,7-cyclooctatetraene)(«eta»5-2,4-cyclopentadien-1-yl)-
|
11065-40-0 |
1 | 217.11 |
| 48-432-9 |
1-Cyclopentadienyl-3-(p-biphenylyl)-1,1,3,3-tetramethyl disiloxane
|
|
1 | 366.65 |
| 49-451-7 |
Nickel, [[2,2'-[oxybis(3,1-propanediylnitrilomethylidyne)]bis[phenolato]](2-)-N,N',O,O',O"]-
|
52279-52-4 |
1 | 397.09 |
| 49-716-3 |
1-Amino-4-bromo-2-anthraquinone sulfonic acid, sodium salt
|
|
1 | 404.17 |
| 50-435-3 |
Pb(II) N,N-bis(2,2,2-trifluoroethyl)dithiocarbamate, chelate
|
|
1 | 719.63 |
|
« Previous Results
Next Results »
|